Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Alimentary Pharmacology & Therapeutics|July 6, 2021
Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux diseaseSeung Han Kim, Kwang Bum Cho, Hoon Jai Chun, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter StudyDa Hyun Jung, Young Hoon Youn, Hye-Kyung Jung, et al.
Journal of Clinical Gastroenterology|January 27, 2009
Clinical spectrum of reflux esophagitis among 25,536 Koreans who underwent a health check-up: a nationwide multicenter prospective, endoscopy-based studyKi-Nam Shim, Su Jin Hong, Jae Kyu Sung, et al.
Gut and Liver|April 28, 2025
Korean Registry on the Current Management of <i>Helicobacter pylori</i> (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line TreatmentHyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, et al.
Journal of Gastric Cancer|April 6, 2026
Nationwide Survey on Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea: Results From the Korean College of <i>Helicobacter</i> and Upper Gastrointestinal Research (KCHUGR) 2023 SurveyJae Yong Park, Jeong Hoon Lee, Tae-Se Kim, et al.
The Korean Journal of Helicobacter and Upper Gastrointestinal Research|March 18, 2026
Nationwide Survey on Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea: Results From the Korean College of Helicobacter and Upper Gastrointestinal Research (KCHUGR) 2023 SurveyJae Yong Park, Jeong Hoon Lee, Tae-Se Kim, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Gut and Liver|January 16, 2026
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric UlcersKyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, et al.
Pageof 7